STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
- Tobacco Dependence
- +6 more
- Varenicline
- +2 more
- Toronto, Ontario, CanadaCentre for Addiction and Mental Health
2022-03-14
Mar 14, 2022U
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
- Oxford, United KingdomUniversity of Oxford
2020-12-18
Dec 18, 2020S
Recruiting
- Delirium
- +16 more
- Dexmedetomidine Hydrochloride Group
- Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
2022-03-14
Mar 14, 2022C
Terminated
- Astrocytoma, Grade IV
- +13 more
- CYNK001-IV
- CYNK001-IT
- Houston, TexasThe Univeristy of Texas MD ANderson Cancer Center
2022-01-24
Jan 24, 2022S
Recruiting
- Hepatocellular Carcinoma
- +7 more
- TACE combined with sorafenib and PD-1 mAb
- Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
2020-09-14
Sep 14, 2020L
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
- Garden Grove, California
- +8 more
2021-11-19
Nov 19, 2021U
Unknown status
- Molecular Mechanisms of Pharmacological Action
- +5 more
- Citalopram
- Placebo oral tablet
- Oxford, United KingdomUniversity of Oxford
2019-11-18
Nov 18, 2019X
Recruiting
- Ovarian Neoplasms
- +23 more
- Nanjing, Jiangsu, ChinaJiangSu Cancer Hospital
2020-11-08
Nov 8, 2020U
Unknown status
- Pharmacokinetics
- Molecular Mechanisms of Pharmacological Action
- Brand name: Andrographis paniculata (Shine Hempedu Bumi) 1000mg capsules
- +2 more
- Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaClinical Investigation Centre, University Malaya Medical Centre
2019-12-23
Dec 23, 2019S
Unknown status
- Delirium
- +9 more
- Wenzhou, Zhejiang, ChinaThe second Affiliated Hospital and Yuying Children's Hospital of
2019-09-23
Sep 23, 2019P
Recruiting
- Muscle Recovery
- 500 ml base solution
- +2 more
- Exeter, UK, United KingdomUniversity of Exeter Sport and Health Sciences Department
2021-01-22
Jan 22, 2021U
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
- Oxford, United KingdomUniversity of Oxford
2019-03-01
Mar 1, 2019F
Not yet recruiting
- Stomach Neoplasms
- +7 more
- (no location specified)
2019-03-23
Mar 23, 2019N
Completed
- Testicular Neoplasms
- +6 more
- Bratislava, SlovakiaNational Cancer Institute
2019-03-03
Mar 3, 2019J
Terminated
- Absence of Signs or Symptoms
- +7 more
- Biospecimen Collection
- +7 more
- Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
2021-07-12
Jul 12, 2021M
Unknown status
- Migraine
- Botulinum toxin type A
- Boston, MassachusettsMassachusetts General Hospital
2019-03-16
Mar 16, 2019B
Completed
- Molecular Mechanisms of Pharmacological Action
- Ruddington, United KingdomQuotient Clinical
2017-10-20
Oct 20, 2017K
Completed
- Remission in Depression
- Intravenous Infusion
- (no location specified)
2020-12-03
Dec 3, 2020U
Recruiting
- Cardiomyopathy, Familial
- Electrocardiogram
- +3 more
- Montpellier, Occitanie, FranceCHU Arnaud de Villeneuve
2020-12-01
Dec 1, 2020A
Recruiting
- Lupus Erythematosus, Systemic
- Blood samples
- Paris, FranceHospital Necker Enfants Malades
2021-09-22
Sep 22, 2021U
Recruiting
- Post-Traumatic Stress Disorders
- Major Depressive Disorder
- Ketamine
- Normal Saline
- Minneapolis, MinnesotaMinneapolis Veterans Affairs Health Care System
2022-01-13
Jan 13, 2022A
Recruiting
- Gastrointestinal Cancer
- Pharmacogenetic test
- Philadelphia, PennsylvaniaUniversity of Pennsylvania
2022-01-18
Jan 18, 2022H
Recruiting
- Neonatal Abstinence Syndrome
- Lexington, KentuckyThe University of Kentucky Medical Center
2021-06-09
Jun 9, 2021U
Recruiting
- Diabetes Mellitus, Type 2
- Metformin / alogliptin Oral Product
- +2 more
- Catanzaro, ItalyASP Catanzaro
2020-09-11
Sep 11, 2020M
Completed
- Posttraumatic Stress Disorder
- Full dose MDMA
- Mount Pleasant, South CarolinaOffices of Michael Mithoefer
2021-09-20
Sep 20, 2021